STIM Neuronetics, Inc. - 8-K

Item 5.07

Submission of Matters to a Vote of Security Holders

Neuronetics, Inc. (the “Company”) held its Annual Meeting of Stockholders on May 28, 2026 (the “Annual Meeting”). A total of 55,950,118 shares of common stock, representing approximately 80.41% of the shares outstanding and eligible to vote and constituting a quorum, were represented in person or by valid proxies at the Annual Meeting. The final results for each of the matters submitted to a vote of stockholders at the Annual Meeting are as follows:

Proposal 1: All of the nominees for director were elected to serve a one-year term until the 2027 Annual Meeting, or until their respective successors are elected and qualified, by the votes set forth in the table below:

Nominees

For

Withheld

Broker

Non-Votes

Avinash N. Amin, M.D.

33,982,534

7,305,990

14,661,594

Robert A. Cascella

29,304,597

11,983,927

14,661,594

Sheryl L. Conley

29,304,311

11,984,213

14,661,594

Sasha S. Cucuz

28,512,554

12,775,970

14,661,594

Glenn P. Muir

29,281,048

12,007,476

14,661,594

Daniel L. Reuvers

34,472,656

6,815,868

14,661,594

Megan R. Rosengarten

28,794,454

12,494,070

14,661,594

Proposal 2: The appointment of KPMG LLP as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2026 was ratified by the Company’s stockholders by the votes set forth in the table below:

47,194,967 votes

FOR the proposal

6,924,816 votes

AGAINST the proposal

1,830,335 votes

ABSTAIN

Proposal 3: The approval, on a non-binding, advisory basis, of the compensation of the individual who served as our principal executive officer during 2025 and our two other most highly compensated executive officers who were serving as executive officers as of December 31, 2025 was ratified by the Company’s stockholders by the votes set forth in the table below:

29,133,360 votes

FOR the proposal

11,503,294 votes

AGAINST the proposal

651,870 votes

ABSTAIN

14,661,594 votes

Broker Non-Votes

Proposal 4: The approval of the Neuronetics, Inc. 2026 Equity Incentive Plan was approved by the Company’s stockholders by the votes set forth in the table below:

23,802,955 votes

FOR the proposal

16,651,661 votes

AGAINST the proposal

833,908 votes

ABSTAIN

14,661,594 votes

Broker Non-Votes